Tarsus Pharmaceuticals, Inc.
TARS
43 insider filings · Latest: Jun 25, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Mar 18 8:17 PM | Azamian Bobak R. | Proposed Sale | 11,667 | $68.71 | $801.6K | — | View → |
| Mar 18, 2026 | Mar 18 8:17 PM | Neervannan Seshadri | Proposed Sale | 3,610 | $68.71 | $248.0K | — | View → |
| Mar 18, 2026 | Mar 18 8:14 PM | Farrow Jeffrey S | Proposed Sale | 2,133 | $68.71 | $146.6K | — | View → |
| Mar 18, 2026 | Mar 18 8:13 PM | Mottiwala Aziz | Proposed Sale | 4,330 | $68.71 | $297.5K | — | View → |
| Mar 18, 2026 | Mar 18 8:11 PM | Lin Elizabeth Yeu | Proposed Sale | 379 | $68.71 | $26.0K | — | View → |
| Mar 16, 2026 | Mar 18 8:11 PM | Phd J Link WilliamDirector | Sale | 12,500 | $68.79 | $859.8K | 116,332(D) | View → |
| Mar 17, 2026 | Mar 17 8:09 PM | Azamian Bobak R. | Proposed Sale | 10,972 | $69.41 | $761.6K | — | View → |
| Mar 17, 2026 | Mar 17 8:07 PM | Neervannan Seshadri | Proposed Sale | 3,125 | $69.41 | $216.9K | — | View → |
| Mar 17, 2026 | Mar 17 8:03 PM | Farrow Jeffrey S | Proposed Sale | 2,111 | $69.41 | $146.5K | — | View → |
| Mar 17, 2026 | Mar 17 7:59 PM | Wahl Bryan | Proposed Sale | 4,084 | $69.41 | $283.5K | — | View → |
| Mar 17, 2026 | Mar 17 7:55 PM | Whitfield Dianne C. | Proposed Sale | 4,029 | $69.41 | $279.7K | — | View → |
| Mar 17, 2026 | Mar 17 7:47 PM | Lin Elizabeth Yeu | Proposed Sale | 375 | $69.41 | $26.0K | — | View → |
| Mar 17, 2026 | Mar 17 7:42 PM | Mottiwala Aziz | Proposed Sale | 4,286 | $69.41 | $297.5K | — | View → |
| Mar 16, 2026 | Mar 16 9:39 PM | WILLIAM J LINK | Proposed Sale | 12,500 | $68.78 | $859.8K | — | View → |
| Mar 4, 2026 | Mar 5 9:03 PM | Seshadri NeervannanChief Operating Officer | Sale | 8,366 | $76.67 | $641.4K | 70,817(D) | View → |
| Mar 4, 2026 | Mar 4 3:56 PM | Neervannan Seshadri | Proposed Sale | 8,366 | $76.67 | $641.4K | — | View → |
| Jan 2, 2026 | Jan 2 4:22 PM | Whitfield Dianne C. | Proposed Sale | 15,565 | $81.38 | $1.3M | — | View → |
| Dec 24, 2025 | Dec 29 5:22 PM | BOBAK AZAMIAN | Proposed Sale | 6,000 | $82.51 | $495.1K | — | View → |
| Dec 16, 2025 | Dec 16 8:12 PM | Lin Elizabeth Yeu | Proposed Sale | 2,078 | $79.50 | $165.2K | — | View → |
| Dec 16, 2025 | Dec 16 3:11 PM | Whitfield Dianne C. | Proposed Sale | 7,397 | $80.10 | $592.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:24 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Option Exercise | 66,274 | — | 44,634(D) | View → |
| Mar 15, 2026 | Mar 17 8:20 PM | Elizabeth Yeu LinChief Medical Officer | Option Exercise | 2,511 | — | 7,534(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bryan WahlGeneral Counsel | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Aziz MottiwalaChief Commercial Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Seshadri NeervannanChief Operating Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Dianne C. WhitfieldChief Human Resources Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Elizabeth Yeu LinChief Medical Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Grant/Award | 157,499 | $74.90 | 60,776(D) | View → |
| Feb 18, 2026 | Feb 20 9:35 PM | I E Pyott DavidDirector | Grant/Award | 9,622 | $63.27 | 3,729(D) | View → |
← Previous
Page 2 of 2